Cryo-EM structures of tau filaments from Alzheimer's disease

Nature

Volumn 547, Issue 7662, 2017, Pages 185-190

  Fitzpatrick, Anthony W P ^a   Falcon, Benjamin ^a   He, Shaoda ^a   Murzin, Alexey G ^a   Murshudov, Garib ^a   Garringer, Holly J ^b   Crowther, R Anthony ^a   Ghetti, Bernardino ^b   Goedert, Michel ^a   Scheres, Sjors H W ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; TAU PROTEIN;

BRAIN; CELLS AND CELL COMPONENTS; DISEASE INCIDENCE; MORPHOLOGY; NERVOUS SYSTEM DISORDER; PROTEIN; ULTRASTRUCTURE;

ALZHEIMER DISEASE; ARTICLE; CRYOELECTRON MICROSCOPY; HUMAN; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PAIRED HELICAL FILAMENT; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; AGED; AMINO ACID SEQUENCE; BRAIN; CHEMISTRY; FEMALE; METABOLISM; PATHOLOGY; PROTEINOSIS; ULTRASTRUCTURE;

AGED; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID; BRAIN; CRYOELECTRON MICROSCOPY; FEMALE; HUMANS; PROTEIN AGGREGATION, PATHOLOGICAL; TAU PROTEINS;

EID: 85024396904     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature23002     Document Type: Article

References (57)

1. Wilcock, G. K. & Esiri, M. M. Plaques, tangles and dementia. A quantitative study. J. Neurol. Sci. 56, 343-356 (1982).
2. Ghetti, B. et al. Frontotemporal dementia caused by microtubule-Associated protein tau gene (MAPT) mutations: A chameleon for neuropathology and neuroimaging. Neuropathol. Appl. Neurobiol. 41, 24-46 (2015).
3. Kidd, M. Paired helical filaments in electron microscopy of Alzheimers disease. Nature 197, 192-193 (1963).
4. Terry, R. D. The fine structure of neurofibrillary tangles in Alzheimers disease. J. Neuropathol. Exp. Neurol. 22, 629-642 (1963).
5. Yagishita, S., Itoh, Y., Nan, W. & Amano, N. Reappraisal of the fine structure of Alzheimers neurofibrillary tangles. Acta Neuropathol. 54, 239-246 (1981).
6. Crowther, R. A. Straight and paired helical filaments in Alzheimer disease have a common structural unit. Proc. Natl Acad. Sci. USA 88, 2288-2292 (1991).
7. Wischik, C. M. et al. Structural characterization of the core of the paired helical filament of Alzheimer disease. Proc. Natl Acad. Sci. USA 85, 4884-4888 (1988).
8. Berriman, J. et al. Tau filaments from human brain and from in vitro assembly of recombinant protein show cross-β structure. Proc. Natl Acad. Sci. USA 100, 9034-9038 (2003).
9. Braak, H. & Del Tredici, K. Potential pathways of abnormal Tau and α-synuclein dissemination in sporadic Alzheimers and Parkinsons diseases. Cold Spring Harb. Perspect. Biol. 8, a023630 (2016).
10. Jackson, S. J. et al. Short fibrils constitute the major species of seed-competent Tau in the brains of mice transgenic for human P301S Tau. J. Neurosci. 36, 762-772 (2016).
11. Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D. & Crowther, R. A. Multiple isoforms of human microtubule-Associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimers disease. Neuron 3, 519-526 (1989).
12. Crowther, R. A. & Goedert, M. Abnormal tau-containing filaments in neurodegenerative diseases. J. Struct. Biol. 130, 271-279 (2000).
13. Guo, J. L. et al. Unique pathological tau conformers from Alzheimers brains transmit tau pathology in nontransgenic mice. J. Exp. Med. 213, 2635-2654 (2016).
14. Schmidt, M. et al. Peptide dimer structure in an Aβ (1-42) fibril visualized with cryo-EM. Proc. Natl Acad. Sci. USA 112, 11858-11863 (2015).
15. Colvin, M. T. et al. Atomic resolution structure of monomorphic Aβ 42 amyloid fibrils. J. Am. Chem. Soc. 138, 9663-9674 (2016).
16. Lu, J.-X. et al. Molecular structure of β-Amyloid fibrils in Alzheimers disease brain tissue. Cell 154, 1257-1268 (2013).
17. Wlti, M. A. et al. Atomic-resolution structure of a disease-relevant Aβ (1-42) amyloid fibril. Proc. Natl Acad. Sci. USA 113, E4976-E4984 (2016).
18. Tuttle, M. D. et al. Solid-state NMR structure of a pathogenic fibril of full-length human α-synuclein. Nat. Struct. Mol. Biol. 23, 409-415 (2016).
19. Goedert, M., Spillantini, M. G., Cairns, N. J. & Crowther, R. A. Tau proteins of Alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms. Neuron 8, 159-168 (1992).
20. McEwan, W. A. et al. Cytosolic Fc receptor TRIM21 inhibits seeded tau aggregation. Proc. Natl Acad. Sci. USA 114, 574-579 (2017).
21. He, S. & Scheres, S. H. W. Helical reconstruction in RELION. J. Struct. Biol. 198, 163-176 (2017).
22. Fitzpatrick, A. W. P. et al. Atomic structure and hierarchical assembly of a cross-β amyloid fibril. Proc. Natl Acad. Sci. USA 110, 5468-5473 (2013).
23. Jakes, R., Novak, M., Davison, M. & Wischik, C. M. Identification of 3-And 4-repeat tau isoforms within the PHF in Alzheimers disease. EMBO J. 10, 2725-2729 (1991).
24. Wischik, C. M. et al. Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc. Natl Acad. Sci. USA 85, 4506-4510 (1988).
25. Taniguchi-Watanabe, S. et al. Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau. Acta Neuropathol. 131, 267-280 (2016).
26. Dan, A. et al. Extensive deamidation at asparagine residue 279 accounts for weak immunoreactivity of tau with RD4 antibody in Alzheimers disease brain. Acta Neuropathol. Commun. 1, 54 (2013).
27. Crick, F. H. C. & Rich, A. Structure of polyglycine II. Nature 176, 780-781 (1955).
28. Jicha, G. A., Bowser, R., Kazam, I. G. & Davies, P. Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J. Neurosci. Res. 48, 128-132 (1997).
29. Bibow, S. et al. The dynamic structure of filamentous tau. Angew. Chem. Int. Edn Engl. 50, 11520-11524 (2011).
30. Carmel, G., Mager, E. M., Binder, L. I. & Kuret, J. The structural basis of monoclonal antibody Alz50s selectivity for Alzheimers disease pathology. J. Biol. Chem. 271, 32789-32795 (1996).
31. Poorkaj, P. et al. An R5L tau mutation in a subject with a progressive supranuclear palsy phenotype. Ann. Neurol. 52, 511-516 (2002).
32. Hayashi, S. et al. Late-onset frontotemporal dementia with a novel exon 1 (Arg5His) tau gene mutation. Ann. Neurol. 51, 525-530 (2002).
33. Clavaguera, F. et al. Brain homogenates from human tauopathies induce tau inclusions in mouse brain. Proc. Natl Acad. Sci. USA 110, 9535-9540 (2013).
34. Sunde, M. et al. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Biol. 273, 729-739 (1997).
35. Govaerts, C., Wille, H., Prusiner, S. B. & Cohen, F. E. Evidence for assembly of prions with left-handed b-helices into trimers. Proc. Natl Acad. Sci. USA 101, 8342-8347 (2004).
36. Kadavath, H. et al. Folding of the Tau protein on microtubules. Angew. Chem. Int. Edn Engl. 54, 10347-10351 (2015).
37. Chiti, F. & Dobson, C. M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75, 333-366 (2006).
38. von Bergen, M. et al. Assembly of t protein into Alzheimer paired helical filaments depends on a local sequence motif (306VQIVYK311) forming b structure. Proc. Natl Acad. Sci. USA 97, 5129-5134 (2000).
39. Xie, C. et al. Identification of key amino acids responsible for the distinct aggregation properties of microtubule-Associated protein 2 and tau. J. Neurochem. 135, 19-26 (2015).
40. Sawaya, M. R. et al. Atomic structures of amyloid cross-b spines reveal varied steric zippers. Nature 447, 453-457 (2007).
41. Gustke, N., Trinczek, B., Biernat, J., Mandelkow, E. M. & Mandelkow, E. Domains of tau protein and interactions with microtubules. Biochemistry 33, 9511-9522 (1994).
42. Kaufman, S. K. et al. Tau prion strains dictate patterns of cell pathology, progression rate, and regional vulnerability in vivo. Neuron 92, 796-812 (2016).
43. Kajava, A. V. & Steven, A. C. b-rolls, b-helices, and other b-solenoid proteins. Adv. Protein Chem. 73, 55-96 (2006).
44. Wasmer, C. et al. Amyloid fibrils of the HET-s(218-289) prion form a b solenoid with a triangular hydrophobic core. Science 319, 1523-1526 (2008).
45. Riek, R. & Eisenberg, D. S. The activities of amyloids from a structural perspective. Nature 539, 227-235 (2016).
46. Herrmann, U. S. et al. Structure-based drug design identifies polythiophenes as antiprion compounds. Sci. Transl. Med. 7, 299ra123 (2015).
47. Aslund, A. et al. Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses. ACS Chem. Biol. 4, 673-684 (2009).
48. Kolb, H. C. & Andrés, J. I. Tau positron emission tomography imaging. Cold Spring Harb. Perspect. Biol. 9, a023721 (2017).
49. Spina, S. et al. The tauopathy associated with mutation + 3 in intron 10 of Tau: characterization of the MSTD family. Brain 131, 72-89 (2008).
50. Falcon, B. et al. Conformation determines the seeding potencies of native and recombinant Tau aggregates. J. Biol. Chem. 290, 1049-1065 (2015).
51. Zheng, S. Q. et al. MotionCor2: Anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331-332 (2017).
52. Zhang, K. Gctf: Real-Time CTF determination and correction. J. Struct. Biol. 193, 1-12 (2016).
53. Chen, S. et al. High-resolution noise substitution to measure overfitting and validate resolution in 3D structure determination by single particle electron cryomicroscopy. Ultramicroscopy 135, 24-35 (2013).
54. Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486-501 (2010).
55. Murshudov, G. N., Vagin, A. A. & Dodson, E. J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53, 240-255 (1997).
56. Iverson, T. M., Alber, B. E., Kisker, C., Ferry, J. G. & Rees, D. C. A closer look at the active site of γ-class carbonic anhydrases: high-resolution crystallographic studies of the carbonic anhydrase from Methanosarcina thermophila. Biochemistry 39, 9222-9231 (2000).
57. Chen, V. B. et al. MolProbity: All-Atom structure validation for macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 66, 12-21 (2010).